| Multiple myeloma therapy: emerging trends and challenges D Dima, D Jiang, DJ Singh, M Hasipek, HS Shah, F Ullah, J Khouri, ... Cancers 14 (17), 4082, 2022 | 29 | 2022 |
| Impact of fibrosis-4 index prior to COVID-19 on outcomes in patients at risk of non-alcoholic fatty liver disease MA Elfeki, J Robles, Z Akhtar, F Ullah, I Ganapathiraju, C Tran, C Inman, ... Digestive Diseases and Sciences 67 (7), 3333-3339, 2022 | 13 | 2022 |
| Precision oncology targets in biliary tract cancer N Farha, D Dima, F Ullah, S Kamath Cancers 15 (7), 2105, 2023 | 7 | 2023 |
| Toxicity profile of chimeric antigen receptor T-cell and bispecific antibody therapies in multiple myeloma: pathogenesis, prevention and management M Markouli, F Ullah, S Unlu, N Omar, N Lopetegui-Lia, M Duco, F Anwer, ... Current Oncology 30 (7), 6330-6352, 2023 | 6 | 2023 |
| Early-Onset Colorectal Cancer: Current Insights F Ullah, AB Pillai, N Omar, D Dima, S Harichand Cancers 15 (12), 3202, 2023 | 6 | 2023 |
| Management of Relapsed–Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice D Dima, F Ullah, S Mazzoni, L Williams, B Faiman, A Kurkowski, ... Cancers 15 (7), 2160, 2023 | 6 | 2023 |
| Advances in the treatment of Hodgkin lymphoma: Current and future approaches F Ullah, D Dima, N Omar, O Ogbue, S Ahmed Frontiers in Oncology 13, 1067289, 2023 | 6 | 2023 |
| Recent advances in adult post-transplant lymphoproliferative disorder M Markouli, F Ullah, N Omar, A Apostolopoulou, P Dhillon, ... Cancers 14 (23), 5949, 2022 | 5 | 2022 |
| Safety and effectiveness of direct oral anticoagulants for the treatment of gastrointestinal cancer-associated venous thromboembolism F Ullah, J Song, CM Rojas Hernandez, MH Kroll, CP Escalante, KM Toale The Oncologist 28 (11), e1005-e1016, 2023 | 2 | 2023 |
| Clinico-Molecular Risk Factors and Management of Thrombosis in a Large Real-Life Cohort of Patients with Paroxysmal Nocturnal Hemoglobinuria in the New Era of Anti-Complement … C Gurnari, H Awada, M Aly, D Dima, F Ullah, N Kawashima, Y Kubota, ... Blood 140 (Supplement 1), 8513-8514, 2022 | 2 | 2022 |
| Splenectomy for Immune Cytopenias: Treatment Outcomes and Predictors of Response O Ogbue, W Bahaj, T Kewan, R Ahmed, F Ullah, V Visconte, S Maskal, ... Blood 140 (Supplement 1), 1226-1227, 2022 | 2 | 2022 |
| Outcomes of Venetoclax-Based Therapy in Patients with Daratumumab-Refractory t (11; 14) Positive Light Chain Amyloidosis M Orland, D Dima, F Ullah, H Awada, D Basali, BM Faiman, C Scott, ... Blood 142, 2031, 2023 | 1 | 2023 |
| Intense Immunosuppressive Therapy (anti-thymocyte globulin, alemtuzumab) As Salvage Therapy in Refractory T-Cell Large Granular Lymphocytic Leukemia and Pure Red Cell Aplasia F Ullah, D Dima, C Gurnari, SK Balasubramanian, O Ogbue, H Awada, ... Blood 140 (Supplement 1), 5795-5796, 2022 | 1 | 2022 |
| Immunotherapy for Head and Neck Squamous Cell Carcinoma: Present and Future Approaches and Challenges MD Orland, F Ullah, E Yilmaz, JL Geiger JCO Oncology Practice, OP. 24.00041, 2024 | | 2024 |
| Large Granular Lymphocytic Leukemia: Clinical Features, Molecular Pathogenesis, Diagnosis and Treatment F Ullah, M Markouli, M Orland, O Ogbue, D Dima, N Omar, MK Mustafa Ali Cancers 16 (7), 1307, 2024 | | 2024 |
| Paroxysmal nocturnal hemoglobinuria-related thrombosis in the era of novel therapies: a 2043 patient/years analysis C Gurnari, H Awada, S Pagliuca, D Dima, F Ullah, N Kawashima, ... Blood, 2024 | | 2024 |
| Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study S Ahmed, Q Bashir, RL Bassett Jr, F Ullah, F Aung, BC Valdez, AM Alousi, ... American Journal of Hematology, 2024 | | 2024 |
| Outcomes of Salvage VDT-PACE-like Regimens in Relapsed-Refractory Multiple Myeloma: 10-Year Experience of a Large Academic Institution A Ahmed, D Dima, K Row, F Ullah, H Awada, D Basali, H Kurish, M Rice, ... Blood 142 (Supplement 1), 4724-4724, 2023 | | 2023 |
| LGL in MGUS or MGUS in LGL? Lessons of Nature and Their Clinical Implications C Bravo-Perez, C Gurnari, N Kawashima, D Dima, O Ogbue, L Guarnera, ... Blood 142 (Supplement 1), 4769-4769, 2023 | | 2023 |
| Outcomes of Antithymocyte Globulin and Cyclosporine for Severe Aplastic Anemia F Ullah, D Dima, C Gurnari, A Ahmed, O Ogbue, M Orland, N Kawashima, ... Blood 142, 5648, 2023 | | 2023 |
